An observational study in Mouth Cancer, Lip Cancer and Throat Cancer, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-05-27.
Sponsored by Stanford University · Observational
381 studies on the registry are indexed under Mouth Neoplasms; 126 are open to participants now.
This study's enrollment of 49 is below the median of 88 across 104 observational studies indexed under Mouth Neoplasms.
Browse Mouth Neoplasms studies →Stanford University is the lead sponsor of 2,161 studies on the registry; 428 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
Counted across the registry records on this site, refreshed daily.
Having a new diagnosis of Nasopharyngeal carcinoma
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Plasma Epstein-Bar Virus (EBV) DNA concentrations
measured by quantitative polymerase chain reaction (PCR)
Time frame: every 6 months until end of study
This study is completed, as verified in May 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.